These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1440386)

  • 1. [The pathogenetic therapy of lupus glomerulonephritis].
    Diadyk AI; Vasilenko IV; Siniachenko OV; Iarova NF; Bagriĭ AE; Khomenko MA; Chernykh OS; Zviagina TV
    Ter Arkh; 1992; 64(8):119-23. PubMed ID: 1440386
    [No Abstract]   [Full Text] [Related]  

  • 2. [The treatment of LED-nephritis].
    Mustonen J
    Duodecim; 1994; 110(11):1090-5. PubMed ID: 7588119
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment protocols of the lupus nephritis collaborative study of plasmapheresis in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group.
    Clough JD; Lewis EJ; Lachin JM
    Prog Clin Biol Res; 1990; 337():301-7. PubMed ID: 2352989
    [No Abstract]   [Full Text] [Related]  

  • 4. [Systemic lupus erythematosus].
    Schröder JO; Euler HH
    Internist (Berl); 1993 Apr; 34(4):351-61. PubMed ID: 8486478
    [No Abstract]   [Full Text] [Related]  

  • 5. [The efficacy of the glucocorticoid and cytostatic therapy of lupus glomerulonephritis].
    Diadyk AI; Vasilenko IV; Siniachenko OV; Iarovaia NF; Shpilevaia NI; Bagriĭ AE; Khomenko MV; Chernykh OS; Efremenko VA; Zviagina TV
    Ter Arkh; 1992; 64(10):111-4. PubMed ID: 1485238
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasmapheresis for lupus nephritis. Lupus Plasmapheresis Study Group.
    Euler HH; Schroeder JO
    N Engl J Med; 1992 Oct; 327(14):1028; author reply 1029-30. PubMed ID: 1518539
    [No Abstract]   [Full Text] [Related]  

  • 7. [Plasmapheresis combined with pharmacology in the treatment of lupus nephritis: a new therapeutic protocol].
    Russo GE; Bonello M; Vitaliano E; Bosco M; Maresca L; De Paola A; Tedaldi M; Bisciglia MF; Bauco B
    Clin Ter; 2000; 151(1):9-13. PubMed ID: 10822875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmapheresis for lupus nephritis.
    Wallace DJ
    N Engl J Med; 1992 Oct; 327(14):1029; author reply 1029-30. PubMed ID: 1518541
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of lupus nephritis: an update.
    Houssiau FA
    J Am Soc Nephrol; 2004 Oct; 15(10):2694-704. PubMed ID: 15466274
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasmapheresis for lupus nephritis.
    Sesso R; Klag M
    N Engl J Med; 1992 Oct; 327(14):1029; author reply 1029-30. PubMed ID: 1518540
    [No Abstract]   [Full Text] [Related]  

  • 11. [Development of lupus nephritis in childhood].
    Ghio L; Edefonti A; Cohen E; Giani M; Miglioli E; Bardare M
    Pediatr Med Chir; 1986; 8(3):325-8. PubMed ID: 3786194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lupus nephritis in the middle of the 20th century and in the beginning of 21st century].
    Tareeva IE; Shilov EM; Krasnova TN; Kozlovskaia LV; Shvetsov MIu; Ianushkevich TN; Samokishina NA
    Ter Arkh; 2001; 73(6):5-10. PubMed ID: 11521523
    [No Abstract]   [Full Text] [Related]  

  • 13. Lupus nephritis: classification, clinical features, and treatment.
    Weissleder R; Galarza DA; Garza MA
    Rev Invest Clin; 1987; 39(3):263-76. PubMed ID: 3324251
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasmapheresis for lupus nephritis.
    Robinson JA
    N Engl J Med; 1992 Oct; 327(14):1028-9; author reply 1029-30. PubMed ID: 1472252
    [No Abstract]   [Full Text] [Related]  

  • 15. [The prognosis for patients with rapidly progressive lupus nephritis under different methods of treatment].
    Tareeva IE; Shilov EM; Krasnova TN; Karpukhin VV; Komiagin IuV; Samoĭlov DV
    Ter Arkh; 1994; 66(6):4-7. PubMed ID: 7940366
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rapidly progressing lupus nephritis].
    Tareeva IE; Ianushkevich TN; Shilov EM; Milovanov IuS; Romanova MD
    Ter Arkh; 1990; 62(6):46-9. PubMed ID: 2218926
    [No Abstract]   [Full Text] [Related]  

  • 17. What do we know about lupus membranous nephropathy? An analytic review.
    Kolasinski SL; Chung JB; Albert DA
    Arthritis Rheum; 2002 Aug; 47(4):450-5. PubMed ID: 12209494
    [No Abstract]   [Full Text] [Related]  

  • 18. [A clinico-pathogenetic approach to choosing the therapeutic procedure in chronic glomerulonephritis].
    Tov NL; Sidorova LD; Valentik MF; Movchan EA; Savitskaia IV; Nekipelova VI; Dorofeev SB; Nesina IA
    Ter Arkh; 1990; 62(6):37-42. PubMed ID: 2218924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The basic methods of treating psoriasis patients].
    Skripkin IuK; Kalamkarian AA; Mandel' ASh; Timoshin GG
    Vestn Dermatol Venerol; 1987; (7):22-7. PubMed ID: 3314235
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of treatment on the survival rate in chronic glomerulonephritis].
    Belovezhdov N; Robeva R; Dimitrova V
    Vutr Boles; 1990; 29(6):29-35. PubMed ID: 2091380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.